BBH ETF (VanEck Biotech ETF) is managed by VanEck with $379.5M in net assets. BBH expense ratio is 0.35%, holding 27 positions across sectors including Health Care, Unknown, Information Technology. Inception date: 2011-12-20.

BBH performance shows a YTD return of 4.07%. The 1-year return is 20.90% and the 5-year return is 2.55%. BBH dividend yield stands at 0.48%, paid annually.

BBH top holdings include Amgen Inc. (15.1%), Gilead Sciences Inc (14.4%), Nvaesrtex Pharmaceuticals Inc (9.1%), Regeneron Pharmaceuticals, Inc. (7.7%), Argenx Se Spon Adr Each Rep 1 Ord Shs (4.7%). View all BBH holdings, sector breakdown, or dividend history.

BBH can be compared against other funds using the overlap calculator or side-by-side comparison tool. BBH alternatives are available via the screener, along with tax-loss harvesting opportunities.